Results 231 to 240 of about 56,579,928 (315)

Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease

open access: yesFEBS Open Bio, EarlyView.
Repair of neuronal DNA damage in Alzheimer's disease by KCL‐286. (A) Amyloid‐β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double‐strand breaks and glial activation. (B) KCL‐286 activates RARβ/RXR signalling via retinoic acid response elements (RAREs), associated with increased BRCA1 expression, enhanced DNA repair and ...
Natasha Hill   +6 more
wiley   +1 more source

Nurse Practitioner Care for Hospitalized Children: A Scoping Review Protocol. [PDF]

open access: yesNurs Rep
Choueiry J   +4 more
europepmc   +1 more source

Implementation evaluation of nurse-initiated care in 29 Australian emergency departments: a RE-AIM multi-method evaluation. [PDF]

open access: yesImplement Sci
Kourouche S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy